{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T04:18:40Z","timestamp":1787545120817,"version":"build-2736575974"},"reference-count":36,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.3724\/abbs.2026096","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:07:46Z","timestamp":1779268066000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Effects and mechanism of pterostilbene on angiotensin II-induced myocardial hypertrophy and fibrosis"],"prefix":"10.3724","author":[{"given":"Jiwei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","volume":"20","author":"Martin TG","year":"2023","unstructured":"Martin TG, Juarros MA, Leinwand LA. Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. Nat Rev Cardiol, 2023, 20: 347-363.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","volume":"18","author":"L\u00f3pez B","year":"2021","unstructured":"L\u00f3pez B, Ravassa S, Moreno MU, San Jos\u00e9 GS, Beaumont J, Gonz\u00e1lez A, D\u00edez J. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol, 2021, 18: 479-498.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/cells11111805","volume":"11","author":"Silva J","year":"2022","unstructured":"Silva J, da Costa Martins PA. Non-coding RNAs in the therapeutic landscape of pathological cardiac hypertrophy. Cells, 2022, 11:","journal-title":"Cells"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5187218","volume":"2022","author":"Yuan J","year":"2022","unstructured":"Yuan J, Yuan G, Ali Sheikh MS. miR-212 promotes cardiomyocyte hypertrophy through regulating transcription factor 7 like 2. Mediators Inflamm, 2022, 2022: 1-10.","journal-title":"Mediators Inflamm"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"154561","DOI":"10.1016\/j.phymed.2022.154561","volume":"109","author":"Shen B","year":"2023","unstructured":"Shen B, Wang Y, Cheng J, Peng Y, Zhang Q, Li Z, Zhao L. Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2. Phytomedicine, 2023, 109:","journal-title":"Phytomedicine"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/0929867326666191029112626","volume":"28","author":"G\u00f3mez-Zorita S","year":"2020","unstructured":"G\u00f3mez-Zorita S, Milton-Lask\u00edbar I, Aguirre L, Fern\u00e1ndez-Quintela A, Xiao J, Portillo MP. Effects of pterostilbene on diabetes, liver steatosis and serum lipids. Curr Med Chem, 2020, 28: 238-252.","journal-title":"Curr Med Chem"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"12836","DOI":"10.1021\/acs.jafc.0c00070","volume":"68","author":"Kim H","year":"2020","unstructured":"Kim H, Seo KH, Yokoyama W. Chemistry of pterostilbene and its metabolic effects. J Agric Food Chem, 2020, 68: 12836-12841.","journal-title":"J Agric Food Chem"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"104265","DOI":"10.1016\/j.phrs.2019.104265","volume":"145","author":"Ma Z","year":"2019","unstructured":"Ma Z, Zhang X, Xu L, Liu D, Di S, Li W, Zhang J.  Pterostilbene: mechanisms of its action as oncostatic agent in cell models and in vivo studies . Pharmacol Res, 2019, 145:","journal-title":"Pharmacol Res"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1159\/000493655","volume":"49","author":"Fan X","year":"2018","unstructured":"Fan X, Wang L, Huang J, Lv H, Deng X, Ci X. Pterostilbene reduces acetaminophen-induced liver injury by activating the Nrf2 antioxidative defense system via the AMPK\/Akt\/GSK3\u03b2 pathway. Cell Physiol Biochem, 2018, 49: 1943-1958.","journal-title":"Cell Physiol Biochem"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejphar.2018.10.008","volume":"842","author":"Gu TT","year":"2019","unstructured":"Gu TT, Chen TY, Yang YZ, Zhao XJ, Sun Y, Li TS, Zhang DM. Pterostilbene alleviates fructose-induced renal fibrosis by suppressing TGF-\u03b21\/TGF-\u03b2 type I receptor\/Smads signaling in proximal tubular epithelial cells. Eur J Pharmacol, 2019, 842: 70-78.","journal-title":"Eur J Pharmacol"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"102007","DOI":"10.1016\/j.redox.2021.102007","volume":"44","author":"Hseu YC","year":"2021","unstructured":"Hseu YC, Vudhya Gowrisankar Y, Wang LW, Zhang YZ, Chen XZ, Huang PJ, Yen HR.  The in vitro and in vivo depigmenting activity of pterostilbene through induction of autophagy in melanocytes and inhibition of UVA-irradiated \u03b1-MSH in keratinocytes via Nrf2-mediated antioxidant pathways . Redox Biol, 2021, 44:","journal-title":"Redox Biol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3724\/abbs.2024181","volume":"57","author":"Gu J","year":"2025","unstructured":"Gu J, Li Z, Li X, Yang Z, Xu X, Wang Y, Li X. MiR-133b-3p attenuates angiotensin II-induced cardiac hypertrophy through the inhibition of apoptosis by targeting CDIP1. Acta Biochim Biophys Sin, 2025, 57: 916-926.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yexcr.2016.05.011","volume":"345","author":"Wang B","year":"2016","unstructured":"Wang B, Wang D, Yan T, Yuan H. MiR-138-5p promotes TNF-\u03b1-induced apoptosis in human intervertebral disc degeneration by targeting SIRT1 through PTEN\/PI3K\/Akt signaling. Exp Cell Res, 2016, 345: 199-205.","journal-title":"Exp Cell Res"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1080\/15384101.2018.1534510","volume":"17","author":"Yu Y","year":"2018","unstructured":"Yu Y, Chen Y, Zhang X, Lu X, Hong J, Guo X, Zhou D. Knockdown of lncRNA KCNQ1OT1 suppresses the adipogenic and osteogenic differentiation of tendon stem cell via downregulating miR-138 target genes PPAR\u03b3 and RUNX2. Cell Cycle, 2018, 17: 2374-2385.","journal-title":"Cell Cycle"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"122290","DOI":"10.1016\/j.lfs.2023.122290","volume":"336","author":"Nie X","year":"2024","unstructured":"Nie X, Xie R, Fan J, Wang DW. LncRNA MIR217HG aggravates pressure-overload induced cardiac remodeling by activating miR-138\/THBS1 pathway. Life Sci, 2024, 336:","journal-title":"Life Sci"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"Diener C","year":"2022","unstructured":"Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet, 2022, 38: 613-626.","journal-title":"Trends Genet"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/biom15030409","volume":"15","author":"Hussey G","year":"2025","unstructured":"Hussey G, Royster M, Vaidy N, Culkin M, Saha MS. The osgin gene family: underexplored yet essential mediators of oxidative stress. Biomolecules, 2025, 15:","journal-title":"Biomolecules"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41388-025-03349-5","volume":"44","author":"Kim DJ","year":"2025","unstructured":"Kim DJ, Yi YW, Dong Z, Seong YS. Therapeutic implication of oxidative stress-induced growth inhibitor 1 (OSGIN1) in cancer. Oncogene, 2025, 44: 997-1006.","journal-title":"Oncogene"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41569-023-00887-x","volume":"20","author":"Ritterhoff J","year":"2023","unstructured":"Ritterhoff J, Tian R. Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. Nat Rev Cardiol, 2023, 20: 812-829.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.3390\/ijms24119707","volume":"24","author":"Surien O","year":"2023","unstructured":"Surien O, Masre SF, Basri DF, Ghazali AR. Potential chemopreventive role of pterostilbene in its modulation of the apoptosis pathway. Int J Mol Sci, 2023, 24:","journal-title":"Int J Mol Sci"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.3390\/molecules25215166","volume":"25","author":"Liu Y","year":"2020","unstructured":"Liu Y, You Y, Lu J, Chen X, Yang Z. Recent advances in synthesis, bioactivity, and pharmacokinetics of pterostilbene, an important analog of resveratrol. Molecules, 2020, 25:","journal-title":"Molecules"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"12788","DOI":"10.1021\/acs.jafc.9b07860","volume":"68","author":"Lin WS","year":"2020","unstructured":"Lin WS, Leland JV, Ho CT, Pan MH. Occurrence, bioavailability, anti-inflammatory, and anticancer effects of pterostilbene. J Agric Food Chem, 2020, 68: 12788-12799.","journal-title":"J Agric Food Chem"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/iid3.490","volume":"9","author":"Xu C","year":"2021","unstructured":"Xu C, Song Y, Wang Z, Jiang J, Piao Y, Li L, Jin S. Pterostilbene suppresses oxidative stress and allergic airway inflammation through AMPK\/Sirt1 and Nrf2\/HO-1 pathways. Immun Inflam Dis, 2021, 9: 1406-1417.","journal-title":"Immun Inflam Dis"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/s41598-025-85144-6","volume":"15","author":"Zhou Y","year":"2025","unstructured":"Zhou Y, Yang Y, Tian R, Cheang WS.  Pterostilbene protects against lipopolysaccharide-induced inflammation and blood-brain barrier disruption in immortalized brain endothelial cell lines in vitro . Sci Rep, 2025, 15:","journal-title":"Sci Rep"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"e2300370","DOI":"10.1002\/mnfr.202300370","volume":"67","author":"Koh YC","year":"2023","unstructured":"Koh YC, Lin SJ, Hsu KY, Nagabhushanam K, Ho CT, Pan MH. Pterostilbene enhances thermogenesis and mitochondrial biogenesis by activating the SIRT1\/PGC-1\u03b1\/SIRT3 pathway to prevent western diet-induced obesity. Mol Nutr Food Res, 2023, 67:","journal-title":"Mol Nutr Food Res"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1161\/CIRCULATIONAHA.123.067373","volume":"149","author":"Dzau VJ","year":"2024","unstructured":"Dzau VJ, Hodgkinson CP. RNA therapeutics for the cardiovascular system. Circulation, 2024, 149: 707-716.","journal-title":"Circulation"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1080\/15384101.2022.2060640","volume":"21","author":"Li X","year":"2022","unstructured":"Li X, Jin Y. Inhibition of miR-182-5p attenuates ROS and protects against myocardial ischemia-reperfusion injury by targeting STK17A. Cell Cycle, 2022, 21: 1639-1650.","journal-title":"Cell Cycle"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/s41467-019-09530-1","volume":"10","author":"Gao F","year":"2019","unstructured":"Gao F, Kataoka M, Liu N, Liang T, Huang ZP, Gu F, Ding J. Therapeutic role of miR-19a\/19b in cardiac regeneration and protection from myocardial infarction. Nat Commun, 2019, 10:","journal-title":"Nat Commun"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"152233","DOI":"10.1016\/j.acthis.2025.152233","volume":"127","author":"Chu T","year":"2025","unstructured":"Chu T, Han Q, Shi H, Li C, Ma Q, Li P, Wang F. Aberration of CA3 functionally mediates the pathogenesis of cardiomyocyte hypertrophy in a miR-138-5p dependent manner. Acta Histochem, 2025, 127:","journal-title":"Acta Histochem"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/jcmm.16093","volume":"26","author":"Hu X","year":"2022","unstructured":"Hu X, Ma R, Cao J, Du X, Cai X, Fan Y. CircSAMD4A aggravates H\/R-induced cardiomyocyte apoptosis and inflammatory response by sponging miR-138-5p. J Cell Mol Medi, 2022, 26: 1776-1784.","journal-title":"J Cell Mol Medi"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"e2308570121","DOI":"10.1073\/pnas.2308570121","volume":"121","author":"Goupil E","year":"2024","unstructured":"Goupil E, Lacroix L, Bri\u00e8re J, Guga S, Saba-El-Leil MK, Meloche S, Labb\u00e9 JC. OSGN-1 is a conserved flavin-containing monooxygenase required to stabilize the intercellular bridge in late cytokinesis. Proc Natl Acad Sci USA, 2024, 121:","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3390\/biomedicines10050992","volume":"10","author":"Khoi CS","year":"2022","unstructured":"Khoi CS, Xiao CQ, Hung KY, Lin TY, Chiang CK. Oxidative stress-induced growth inhibitor (OSGIN1), a target of X-box-binding protein 1, protects palmitic acid-induced vascular lipotoxicity through maintaining autophagy. Biomedicines, 2022, 10:","journal-title":"Biomedicines"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"151015","DOI":"10.1016\/j.bbrc.2024.151015","volume":"740","author":"Jia Y","year":"2024","unstructured":"Jia Y, Zhang X, Cai Y, Yu H, Cao G, Dai E, Kang R. OSGIN1 promotes ferroptosis resistance by directly enhancing GCLM activity. Biochem Biophys Res Commun, 2024, 740:","journal-title":"Biochem Biophys Res Commun"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"2022\/9784081","DOI":"10.34133\/2022\/9784081","volume":"2022","author":"Zheng Y","year":"2022","unstructured":"Zheng Y, Sun W, Wang Z, Liu J, Shan C, He C, Li B. Activation of pancreatic acinar FXR protects against pancreatitis via Osgin1-mediated restoration of efficient autophagy. Research, 2022, 2022:","journal-title":"Research"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00018-023-04931-4","volume":"80","author":"Xie X","year":"2023","unstructured":"Xie X, Laster KV, Li J, Nie W, Yi YW, Liu K, Seong YS. OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer. Cell Mol Life Sci, 2023, 80:","journal-title":"Cell Mol Life Sci"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbrc.2014.01.016","volume":"444","author":"Yan X","year":"2014","unstructured":"Yan X, Lee S, Gugiu BG, Koroniak L, Jung ME, Berliner J, Cheng J. Fatty acid epoxyisoprostane E2 stimulates an oxidative stress response in endothelial cells. Biochem Biophys Res Commun, 2014, 444: 69-74.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/92B1DA3F516F4CF9828813318DD28A86","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026096","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/92B1DA3F516F4CF9828813318DD28A86","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:19:59Z","timestamp":1787541599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":36,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026096","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}